Ultragenyx Pharmaceutical | RARE - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
BioCryst Pharmaceuticals USD 395.4M 203K 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Immunic USD 0 0 2024-06
Insmed USD 543.51M 1.3M 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
Kyowa Hakko Kirin JPY 24.12B 5.27B 2024-12
MacroGenics USD 68.71M 1.29M 2026-03
Moderna USD 597M 6M 2026-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
PTC Therapeutics USD 535.52M 248.58M 2026-06
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12